The mRNA levels of the proliferation-promoting genes PCNA and mostly MAD2L1, shown to be overexpressed in BC and associated with aggressive tumors and worse prognosis and BC cell proliferation [31], were also reduced by siRNA-mediated DLL1 downregulation (1.7- and 3.7-fold, respectively). The gene discussed is MAD2L1; the disease is breast cancer.